Database
User
| Compound | Dose | Time | Species | Model | Method | Action | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Metformin | 5mM | 30 minutes | mouse; C57BL/6J | isolated skeletal muscle mitochondria | Meassurement of alpha-ketoglutarate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Metformin | 5mM | 30 minutes | mouse; C57BL/6J | isolated skeletal muscle mitochondria | Meassurement of alpha-ketoglutarate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Metformin | 5mM | 30 minutes | mouse; C57BL/6J | isolated skeletal muscle mitochondria | Meassurement of succinate concentration | decrease | Positive | p < 0.05 | 172 |
| Metformin | 5mM | 30 minutes | mouse; C57BL/6J | isolated skeletal muscle mitochondria | Meassurement of succinate concentration | decrease | Positive | p < 0.05 | 172 |
| Fluoroacetate | affect | Positive | 173 | ||||||
| Rosiglitazone | 1uM | 24 and 48 hours | Murine | adipocytes | Citrate Synthase Activity | affect | Positive | 179 | |
| Polymyxin B | 1.6 μg/ml | Mycobacterium smegmatis | membrane-bound dehydrogenases | affect | Positive | IC50 | 76 | ||
| nanaomycin a | 31 μg/ml | Mycobacterium smegmatis | membrane-bound dehydrogenases | affect | Positive | IC50 | 76 | ||
| oxaloacetate | affect | Positive | 79 | ||||||
| malate | affect | Positive | 79 | ||||||
| citrate | affect | Positive | 79 | ||||||
| fumarate | affect | Positive | 79 | ||||||
| Metformin | 0.5mM | 24 hours | human | MCF10A | Meassurement of citrate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Metformin | 0.5mM | 24 hours | human | MCF7 | Meassurement of citrate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Metformin | 0.5mM | 24 hours | human | MCF10A | Meassurement of isocitrate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Metformin | 0.5mM | 24 hours | human | MCF7 | Meassurement of isocitrate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Metformin | 0.5mM | 24 hours | human | MCF10A | Meassurement of alpha-ketoglutarate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Fluoroacetate | Positive | 251 | |||||||
| Metformin | 0.5mM | 24 hours | human | MCF7 | Meassurement of alpha-ketoglutarate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Tianeptine | 0.5 mM | mouse | The activity of the tricarboxylic acid cycle, assessed as the in vitro formation of [14C]CO2 from [1-14C]acetylcoenzyme A in vitro. | affect | Positive | 237 | |||
| tetracyclines | mouse | liver mitochondria | Tricarboxylic acid cycle activity was assessed by the in vitro formation of [14C]CO2 from [1-14C]acetylcoenzyme A by mouse liver mitochondria. | affect | Positive | 236 | |||
| Metformin | 5mM | 30 minutes | mouse; C57BL/6J | isolated skeletal muscle mitochondria | Meassurement of citrate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |
| Metformin | 5mM | 30 minutes | mouse; C57BL/6J | isolated skeletal muscle mitochondria | Meassurement of citrate concentration; compared with MCF10A | affect | Positive | p < 0.05 | 172 |